Sherman Rachel E.

SEC source: 0001209191-23-027339 · doc4.xml · derivative · entry 2

Sherman Rachel E. · CIK 0001784705 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 45,454 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.

F2 · derivative.exercise_date: The underlying shares shall vest on the earlier of the (a) date of the 2023 annual meeting of the Issuer's stockholders, and (b) first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer on the applicable vesting date.

F2 · derivative.expiration_date: The underlying shares shall vest on the earlier of the (a) date of the 2023 annual meeting of the Issuer's stockholders, and (b) first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer on the applicable vesting date.

SEC source: 0001209191-23-027339 · doc4.xml · nonDerivative · entry 1

Sherman Rachel E. · CIK 0001784705 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,290

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-22-005906 · form4-05312022_040520.xml · derivative · entry 1

Sherman Rachel E. · CIK 0001784705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2032-05-25

F1 · derivative.exercise_date: This option vests in ratable monthly installments over one year from the date of grant.

SEC source: 0001209191-22-027292 · doc4.xml · derivative · entry 2

Sherman Rachel E. · CIK 0001784705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,454

Underlying: Class A Common Stock · 45,454 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.

F1 · derivative.exercise_date: The underlying shares shall vest the earlier of (a) the date of the next annual meeting of the Issuer's shareholders following the grant date, and (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date.

F1 · derivative.expiration_date: The underlying shares shall vest the earlier of (a) the date of the next annual meeting of the Issuer's shareholders following the grant date, and (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date.

SEC source: 0001209191-22-027292 · doc4.xml · derivative · entry 1

Sherman Rachel E. · CIK 0001784705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,914

Underlying: Class A Common Stock · 78,914 shares

Expires 2032-05-01

F1 · derivative.exercise_date: The underlying shares shall vest the earlier of (a) the date of the next annual meeting of the Issuer's shareholders following the grant date, and (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date.

SEC source: 0001209191-22-027690 · doc4a.xml · derivative · entry 1

Sherman Rachel E. · CIK 0001784705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,914

Underlying: Class A Common Stock · 78,914 shares

Expires 2032-05-01

F1 · derivative.exercise_price: This Form 4 amendment has been filed solely to correct the exercise price of a previously issued stock option to purchase shares of Class A Common Stock of the Issuer reported in a Form 4 filed on May 4, 2022 (the "Form 4"). The exercise price was inadvertently stated as $2.155 in the Form 4. The exercise price should have been stated as $2.20 in the Form 4.

F2 · derivative.exercise_date: The underlying shares shall vest the earlier of (a) the date of the next annual meeting of the Issuer's shareholders following the grant date, and (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date.

SEC source: 0001209191-22-028696 · doc4.xml · derivative · entry 2

Sherman Rachel E. · CIK 0001784705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 12,836 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.

F2 · derivative.exercise_date: The RSUs will vest on the earlier of (i) the date of the next annual meeting of the Company's shareholders following the grant date and (i) the first anniversary of the grant date, in each case so long as the non-employee director continues to provide services to the Company through such vesting date.

F2 · derivative.expiration_date: The RSUs will vest on the earlier of (i) the date of the next annual meeting of the Company's shareholders following the grant date and (i) the first anniversary of the grant date, in each case so long as the non-employee director continues to provide services to the Company through such vesting date.

SEC source: 0001209191-22-028696 · doc4.xml · nonDerivative · entry 1

Sherman Rachel E. · CIK 0001784705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,836

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.

SEC source: 0001209191-21-069335 · doc4.xml · derivative · entry 1

Sherman Rachel E. · CIK 0001784705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,659

Underlying: Class A Common Stock · 31,659 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration, granted pursuant to the terms of that certain Agreement and Plan of Merger, dated as of February 9, 2021 (as amended, the "Merger Agreement"), by and among CM Life Sciences, Inc., S-IV Sub, Inc. and Mount Sinai Genomics, Inc. d/b/a Sema4. In addition, in the event that any similar RSUs are forfeited (for example, as a result of the recipient no longer being an employee of the Issuer), the Merger Agreement provides for the shares underlying such forfeited RSUs to become available for issuance to other RSU recipients. Therefore, each RSU also represents to right to receive additional shares of the Issuer's Class A Common Stock from this "forfeiture pool". The number of shares of the Issuer's Class A Common Stock that may be issued to the Reporting Person pursuant to the "forfeiture pool" is not determinable at this time.

F2 · derivative.exercise_price: [cont'd from footnote 1] Any shares of the Issuer's Class A Common Stock ultimately issued to the Reporting Person in respect of each RSU will be reported in a subsequent filing.

F3 · derivative.exercise_date: The vesting of the RSUs is conditioned on the satisfaction of both a service requirement and a market-based requirement. The service requirement is deemed satisfied as of the grant date with respect to 11,872 of the RSUs, and will be satisfied with respect to the remainder of the RSUs over 10 quarterly periods, subject to the Reporting Person's continued service to the Issuer on each service-based vesting date.

F3 · derivative.expiration_date: The vesting of the RSUs is conditioned on the satisfaction of both a service requirement and a market-based requirement. The service requirement is deemed satisfied as of the grant date with respect to 11,872 of the RSUs, and will be satisfied with respect to the remainder of the RSUs over 10 quarterly periods, subject to the Reporting Person's continued service to the Issuer on each service-based vesting date.

SEC source: 0001209191-21-061032 · doc4.xml · derivative · entry 2

Sherman Rachel E. · CIK 0001784705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,836

Underlying: Class A Common Stock · 12,836 shares

Expires not disclosed

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.

F1 · derivative.exercise_date: The stock options and restricted stock units ("RSUs") will vest on the earlier of (i) the date of the next annual meeting of the Issuer's shareholders following the grant date and (i) the first anniversary of the grant date, in each case so long as the Reporting Person continues to provide services to the Issuer through such vesting date.

F1 · derivative.expiration_date: The stock options and restricted stock units ("RSUs") will vest on the earlier of (i) the date of the next annual meeting of the Issuer's shareholders following the grant date and (i) the first anniversary of the grant date, in each case so long as the Reporting Person continues to provide services to the Issuer through such vesting date.

SEC source: 0001209191-21-061032 · doc4.xml · derivative · entry 1

Sherman Rachel E. · CIK 0001784705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,286

Underlying: Class A Common Stock · 22,286 shares

Expires 2031-10-14

F1 · derivative.exercise_date: The stock options and restricted stock units ("RSUs") will vest on the earlier of (i) the date of the next annual meeting of the Issuer's shareholders following the grant date and (i) the first anniversary of the grant date, in each case so long as the Reporting Person continues to provide services to the Issuer through such vesting date.

SEC source: 0001209191-21-048226 · doc4.xml · derivative · entry 1

Sherman Rachel E. · CIK 0001784705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 363,223

Underlying: Class A Common Stock · 363,223 shares

Expires 2030-02-17

F2 · price: Pursuant to the business combination between the Issuer (which was formerly known as CM Life Sciences, Inc.) and Mount Sinai Genomics, Inc. d/b/a Sema4 ("Sema4"), each share of Sema4 outstanding common stock was automatically converted into the right to shares of the Issuer's Class A Common Stock based on a 1 to 123.8338 exchange ratio ("Exchange Ratio"). In addition, each outstanding Sema4 equity award was automatically converted into a corresponding equity award of the Issuer based on the Exchange Ratio and with the same terms and vesting conditions as the Sema4 equity awards.

F1 · derivative.exercise_date: 6.25% of the total shares underlying the option vest in quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.

SEC source: 0001415889-21-002736 · form4-06012021_010626.xml · derivative · entry 1

Sherman Rachel E. · CIK 0001784705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2031-05-26

F1 · derivative.exercise_date: This option vests in ratable monthly installments over one year from the date of grant.

SEC source: 0001104659-20-065364 · a4.xml · derivative · entry 1

Sherman Rachel E. · CIK 0001784705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2030-05-19

F1 · derivative.exercise_date: This option vests in ratable monthly installments over one year from the date of grant.

SEC source: 0001567619-20-001460 · doc1.xml · nonDerivative · entry 1

Sherman Rachel E. · CIK 0001784705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,174

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.74 to $4.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

SEC source: 0001567619-19-017887 · doc1.xml · derivative · entry 1

Sherman Rachel E. · CIK 0001784705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2029-08-29

F1 · derivative.exercise_date: This option vests over a three-year period with one-third of the option vesting on the first anniversary of the date of grant and the remaining two-thirds vesting in ratable monthly installments thereafter.